Michael Adair (M Adair)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Molecularly Imprinted

Decision Making

Clinical Practice

Major Depressive Disorder

Top Venues

Journal of psychopharmacology (Oxford, England)

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

David S Baldwin, Michael Adair, Arun Micheelsen, Daniel Oudin Åstrøm, Elin H Reines
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice. Current medical research and opinion (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
David S Baldwin, Michael Adair, Arun Micheelsen, Daniel Oudin Åstrøm, Elin H Reines
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice. Current medical research and opinion 40 (3) (2024)
David S Baldwin, Michael Adair, Arun Micheelsen, Daniel Oudin Åstrøm, Elin H Reines
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice. Current medical research and opinion 40 (3) (2024)
David S Baldwin, Michael Adair, Arun Micheelsen, Daniel Oudin Åstrøm, Elin H Reines
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice. Current medical research and opinion 40 (3) (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Michael Cronquist Christensen, Roger S McIntyre, Michael Adair, Ioana Florea, Henrik Loft, Andrea Fagiolini
Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder. CNS spectrums (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) 38 (2) (2023)
Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen, Johan Areberg, Michael Cronquist Christensen
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets. Journal of psychopharmacology (Oxford, England) (2023)
Susana S Almeida, Michael Cronquist Christensen, Kenneth Simonsen, Michael Adair
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study. Journal of psychopharmacology (Oxford, England) (2022)